FDA Issues Warning Letter to Principal Investigator: The Excuse Pushed us to Report on the Incident

FDA Issues Warning Letter to Principal Investigator: The Excuse Pushed us to Report on the Incident

Earlier this year, the Food and Drug Administration’s (FDA) Bioresearch Monitoring Program summarized an inspection of principal investigator (PI) Susan P. King-Harris, D.P.M., who was conducting a sponsor-initiated clinical trial involving bunion surgery. Led by the...

Pin It on Pinterest